Auckland Jobs |
Canterbury Jobs |
Northland Jobs |
Otago Jobs |
Southland Jobs |
Tasman Jobs |
Wellington Jobs |
West Coast Jobs |
Auckland Jobs |
Canterbury Jobs |
Northland Jobs |
Otago Jobs |
Southland Jobs |
Tasman Jobs |
Wellington Jobs |
West Coast Jobs |
Oil & Gas Jobs |
Banking Jobs |
Construction Jobs |
Top Management Jobs |
IT - Software Jobs |
Medical Healthcare Jobs |
Purchase / Logistics Jobs |
Sales |
Ajax Jobs |
Designing Jobs |
ASP .NET Jobs |
Java Jobs |
MySQL Jobs |
Sap hr Jobs |
Software Testing Jobs |
Html Jobs |
Job Location | Chaldecutt |
Education | Not Mentioned |
Salary | Not Mentioned |
Industry | Not Mentioned |
Functional Area | Not Mentioned |
Job Type | Permanent |
November 27, 2023 Job ID: 23122AbCellera is breaking the barriers of conventional antibody discovery to bring better medicines to patients, sooner. Our engine integrates expert teams, technology, and facilities with the data science and automation needed to propel antibody-based medicines from target to clinic with precision and speed.The Head of Downstream Process Development (CMC Development), will be responsible for building a team and designing facilities to meet an audacious goal: to go from Discovery to fill-finish in a year. You will be given the freedom to move at lightning speed to create a legacy in our industry.We #39;re offering a generous compensation package including an equity stake in AbCellera #39;s success. Our future facility will be nestled in the heart of Vancouver, Canada - we #39;ll support you and your family in every way we can to relocate if you haven #39;t had the joy of living in this beautiful area!As a key leader within our newly created CMC organization, you will have the exciting opportunity to build our new process development platform from the ground up, all while leveraging cutting-edge technologies. As you lead process development for therapeutic candidates that will be produced in our new GMP facility, you have a strong desire to support early antibody discovery work by developing ways to improve and speed up the discovery to CMC development to GMP manufacturing paradigm. You will build our capacity to support our partners #39; rapid transitions from target identification to clinical testing across therapeutic areas including oncology, inflammation, cardiovascular disease, pain, neurodegeneration, and more.We #39;d love to hear from you if